Sign Up Today and Learn More About Curi Bio Stock
Invest in or calculate the value of your shares in Curi Bio or other pre-IPO companies through EquityZen's platform.
Curi Bio Stock
Curi Bio integrates human stem cells, systems, and AI-enabled data analytics for the development of new therapeutics.
About Curi Bio Stock
Founded
2015
Headquarters
Seattle, WA, US
Industries
Travel and Tourism, Space, Transportation
Curi Bio Press Mentions
Stay in the know about the latest news on Curi Bio
Curi Bio Expands Asia Presence With New APAC Subsidiary
builtinseattle • Jan 14, 2026
Curi Bio Establishes Asia-Pacific Hub Following Full Acquisition Of South Korea’s Quvit Bio
pulse2 • Jan 13, 2026
Curi Bio Launches Asia-Pacific Hub, Delivering Greater Support to its Growing APAC Business
businesswire • Jan 12, 2026
The Weekly Notable Startup Funding Report: 12/8/25
alleywatch • Dec 09, 2025
Curi Bio: $10 Million Series B Closed To Scale Human-Relevant Preclinical Platforms
pulse2 • Dec 05, 2025
Curi Bio Management
Leadership team at Curi Bio
Director of Sales and Marketing
Heejoon Choi
Chief Science Officer
Nicholas Geisse
Join now and verify your accreditation status to gain access to:
- Curi Bio Current Valuation
- Curi Bio Stock Price
- Curi Bio Management
- Available deals in Curi Bio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Curi Bio Cap Table and Funding History by Share Class and Liquidity Preferences
- Curi Bio Revenue and Financials
- Curi Bio Highlights
- Curi Bio Business Model
- Curi Bio Risk Factors
- Curi Bio Research Report from SACRA Research
Trading Curi Bio Stock
How to invest in Curi Bio stock?
Accredited investors can buy pre-IPO stock in companies like Curi Bio through EquityZen funds. These investments are made available by existing Curi Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Curi Bio stock?
Shareholders can sell their Curi Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 420K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."